Masimo Corporation (MASI) has announced a partnership with Qualcomm Technologies to create a nextgeneration smartwatch reference platform for Wear OS by Google. The collaboration is aimed at combining Masimo's expertise in advanced biosensing technologies with Qualcomm's Snapdragon wearable platforms. This reference platform is expected to help original equipment manufacturers (OEMs) develop high-performing smartwatches more efficiently, providing accurate health tracking and superior connectivity through l ...

After tangling in court with Apple over smartwatch features, medical technology company Masimo is teaming with Google. The company announced in a news release Saturday (Sept. 14) that it was working with Google to develop a new reference platform for original equipment manufacturers (OEMs) building the tech giant's Wear OS smartwatches. The platform, the company said, will allow OEMs to more efficiently bring Wear watches to market, incorporating Masimo's biosensing technologies and standardizing smartwatch ...

For Immediate Release Chicago, IL – September 16, 2024 – Today, Zacks Equity Research discusses Intuitive Surgical (ISRG) , Masimo Corp. (MASI) and Veracyte, Inc. (VCYT) . Industry: Medical Instruments Link: https://www.zacks.com/commentary/2335903/3-medical-instruments-industry-stocks-to-buy-on-genaiand-ma-boost The Medical Instruments industry is again in a transformative phase, thanks to the rapid adoption of generative Artificial Intelligence (genAI) and digital therapeutics, which market watchers expec ...

Masimo Corporation (MASI) , on Monday, announced that France-based Saint-Denis Hospital Center will be adopting the use of its SafetyNet cloud-based telemonitoring platform as part of an experimental mobile neonatology unit aimed at facilitating earlier discharge of premature newborns from the ICU to the home. Launched in February, the project is expected to allow vulnerable neonates to return home safely while remaining under the close supervision of the hospital. Although the deal with Saint-Denis Hospita ...

Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it was released to the public, according to court filings. The documents, partially unsealed on Friday, are related to ongoing litigation between Politan and Masimo, which makes devices for monitoring the amount of blood in a person's oxygen. Politan is seeking to replace two directors, including Kiani, with its o ...

Masimo (MASI) closed the last trading session at $114.02, gaining 3.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $145.33 indicates a 27.5% upside potential. The mean estimate comprises six short-term price targets with a standard deviation of $33.38. While the lowest estimate of $86 indicates a 24.6% decline from the current price level, the most optimistic analyst expects th ...

Earlier this month, Masimo subpoenaed proxy advisors ISS and Glass Lewis for their private communications with investors about the upcoming proxy contest with activist Politan Capital, according to people familiar with the matter. The unusual move comes after the medical device company delayed its annual meeting and sued Politan Capital in federal court earlier this summer. Masimo founder Joe Kiani, a close confidante of President Joe Biden, has framed the upcoming vote as existential. Glass Lewis disclosed ...

Masimo's Consumer Business Separation - Masimo has received unsolicited inbound requests from several entities to acquire its consumer audio business following the expiry of the exclusivity period for a potential joint venture [1] - In May, Masimo entered into a non-binding term sheet to sell the majority stake in its consumer audio and consumer health businesses for $850-$950 million on a cash and debt-free basis [2] - The current term sheet offer is lower than the acquisition price paid by Masimo, implying a potential loss for shareholders [3] - Masimo may separate its business through a joint venture, spin-off, or complete sale of the consumer audio business, while retaining its professional healthcare and telehealth/telemonitoring products [4] - Masimo paid over $1 billion to acquire Viper Holdings Corporation in 2022, adding the consumer business to its portfolio [6] - Activist investor Politan Capital has been pressuring for the separation of the consumer business and is concerned about the transfer of IP rights [7] - Masimo will choose the separation path based on the unanimous decision of its board of directors, aiming to meet its long-term goal of $8 earnings per share in five years [8] Masimo's Financial Performance and Industry Comparison - Masimo's shares have risen 5.3% year to date, compared to the industry's 7.2% growth and the S&P 500's 16.5% increase [4] Masimo's Product Portfolio Expansion - Masimo received FDA 510(k) clearance for its W1 medical watch, which can be integrated with the Masimo SafetyNet telemonitoring solution [9] - Masimo announced Sleep Halo, a new feature for its W1 Sport wearable, offering overnight sleep data tracking with over 70,000 daily measurements [10] Other Top-Ranked Medical Stocks - DaVita (DVA) has an estimated long-term growth rate of 17.5%, with earnings surpassing estimates in each of the trailing four quarters and shares rising 43.4% year to date [12] - Aspen Technology (AZPN) has an estimated long-term growth rate of 13.1%, with earnings surpassing estimates in two of the trailing four quarters and shares losing 4.2% year to date [12][13] - Universal Health Services (UHS) has an estimated long-term growth rate of 19%, with earnings surpassing estimates in each of the trailing four quarters and shares rising 48.6% year to date [13]

Masimo Corporation (MASI) recently announced the receipt of the FDA's 510(k) clearance for its W1 medical watch. The approval allows the watch to be integrated with the Masimo SafetyNet comprehensive telemonitoring solution. The Masimo W1 medical watch and the integrated Masimo MW-1 module are indicated for adults in hospitals, clinics, long-term care facilities and homes. It is worthwhile to note that the Masimo W1 medical watch received the FDA's clearance last year as the first medical watch to provide c ...

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Masimo Corporation (NASDAQ: MASI) on behalf of long-term stockholders following a class action complaint that was filed against Masimo on August 22, 2023 with a Class Period from February 28, 2023 to July 17, 2023. Our investigation concerns whether the board of directors of Masimo have breached their fiduciary duties to the company. The comp ...